rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-5-16
|
pubmed:abstractText |
Vascular calcification is thought to be associated with a high cardiovascular mortality rate in patients with end-stage renal disease. Control of hyperphosphataemia is important for the treatment of the vascular calcification. The aim of the present study was to evaluate the effects of sevelamer hydrochloride on the progression of aortic calcification in haemodialysis (HD) patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1660-2110
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
c278-83
|
pubmed:meshHeading |
pubmed-meshheading:18434749-Aged,
pubmed-meshheading:18434749-Analysis of Variance,
pubmed-meshheading:18434749-Aorta, Abdominal,
pubmed-meshheading:18434749-Aortic Diseases,
pubmed-meshheading:18434749-Biological Markers,
pubmed-meshheading:18434749-C-Reactive Protein,
pubmed-meshheading:18434749-Calcinosis,
pubmed-meshheading:18434749-Calcium,
pubmed-meshheading:18434749-Calcium Carbonate,
pubmed-meshheading:18434749-Chelating Agents,
pubmed-meshheading:18434749-Disease Progression,
pubmed-meshheading:18434749-Female,
pubmed-meshheading:18434749-Humans,
pubmed-meshheading:18434749-Kidney Failure, Chronic,
pubmed-meshheading:18434749-Lipids,
pubmed-meshheading:18434749-Male,
pubmed-meshheading:18434749-Middle Aged,
pubmed-meshheading:18434749-Parathyroid Hormone,
pubmed-meshheading:18434749-Phosphorus,
pubmed-meshheading:18434749-Polyamines,
pubmed-meshheading:18434749-Renal Dialysis,
pubmed-meshheading:18434749-Severity of Illness Index,
pubmed-meshheading:18434749-Statistics, Nonparametric,
pubmed-meshheading:18434749-Tomography, X-Ray Computed
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
|
pubmed:affiliation |
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|